Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Gut|March 1, 1979
Relationship between endotoxaemia and protein concentration of ascites in cirrhotic patientsK Tarao, T Moroi, Y Nagakura, et al.
Prosthetics and Orthotics International|June 5, 2002
%VO2max as an indicator of prosthetic rehabilitation outcome after dysvascular amputationT Chin, S Sawamura, H Fujita, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2001
Neurometer measurement of current stimulus threshold in ratsT Kiso, Y Nagakura, T Toya, et al.
Chemical & Pharmaceutical Bulletin|February 13, 1999
Synthesis of the selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist (+)-(S)-2-chloro-5-methoxy-4-[5-(2-piperidylmethyl)-1,2,4-oxadiazol-3-y l]anilineT Suzuki, K Iwaoka, N Imanishi, et al.
Prosthetics and Orthotics International|August 1, 1997
The efficacy of the one-leg cycling test for determining the anaerobic threshold (AT) of lower limb amputeesT Chin, S Sawamura, H Fujita, et al.
Prosthetics and Orthotics International|June 4, 1999
The efficacy of physiological cost index (PCI) measurement of a subject walking with an Intelligent ProsthesisT Chin, S Sawamura, H Fujita, et al.
Journal of Rehabilitation Research and Development|April 27, 2001
Effect of endurance training program based on anaerobic threshold (AT) for lower limb amputeesT Chin, S Sawamura, H Fujita, et al.
Neuroscience|January 18, 2015
Relationship between serotonin transporter occupancies and analgesic effects of AS1069562, the (+)-isomer of indeloxazine, and duloxetine in reserpine-induced myalgia ratsN Murai, H Fushiki, S Honda, et al.
European Journal of Pain (London, England)|March 28, 2012
Automated measurement of spontaneous pain-associated limb movement and drug efficacy evaluation in a rat model of neuropathic painS Kawasaki-Yatsugi, Y Nagakura, S Ogino, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in ratsA Nishida, Y Takinami, H Yuki, et al.
Pageof 4